349 related articles for article (PubMed ID: 19616545)
1. Inhibition of CXCR2 signaling promotes recovery in models of multiple sclerosis.
Kerstetter AE; Padovani-Claudio DA; Bai L; Miller RH
Exp Neurol; 2009 Nov; 220(1):44-56. PubMed ID: 19616545
[TBL] [Abstract][Full Text] [Related]
2. Myelin repair is accelerated by inactivating CXCR2 on nonhematopoietic cells.
Liu L; Darnall L; Hu T; Choi K; Lane TE; Ransohoff RM
J Neurosci; 2010 Jul; 30(27):9074-83. PubMed ID: 20610741
[TBL] [Abstract][Full Text] [Related]
3. Endogenous leukemia inhibitory factor production limits autoimmune demyelination and oligodendrocyte loss.
Butzkueven H; Emery B; Cipriani T; Marriott MP; Kilpatrick TJ
Glia; 2006 May; 53(7):696-703. PubMed ID: 16498619
[TBL] [Abstract][Full Text] [Related]
4. Disrupted CXCR2 Signaling in Oligodendroglia Lineage Cells Enhances Myelin Repair in a Viral Model of Multiple Sclerosis.
Marro BS; Skinner DD; Cheng Y; Grist JJ; Dickey LL; Eckman E; Stone C; Liu L; Ransohoff RM; Lane TE
J Virol; 2019 Sep; 93(18):. PubMed ID: 31243125
[TBL] [Abstract][Full Text] [Related]
5. Increase in chemokine CXCL1 by ERβ ligand treatment is a key mediator in promoting axon myelination.
Karim H; Kim SH; Lapato AS; Yasui N; Katzenellenbogen JA; Tiwari-Woodruff SK
Proc Natl Acad Sci U S A; 2018 Jun; 115(24):6291-6296. PubMed ID: 29844175
[TBL] [Abstract][Full Text] [Related]
6. Role for CXCR2 and CXCL1 on glia in multiple sclerosis.
Omari KM; John G; Lango R; Raine CS
Glia; 2006 Jan; 53(1):24-31. PubMed ID: 16086366
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of soluble tumour necrosis factor is therapeutic in experimental autoimmune encephalomyelitis and promotes axon preservation and remyelination.
Brambilla R; Ashbaugh JJ; Magliozzi R; Dellarole A; Karmally S; Szymkowski DE; Bethea JR
Brain; 2011 Sep; 134(Pt 9):2736-54. PubMed ID: 21908877
[TBL] [Abstract][Full Text] [Related]
8. FGF/FGFR Pathways in Multiple Sclerosis and in Its Disease Models.
Rajendran R; Böttiger G; Stadelmann C; Karnati S; Berghoff M
Cells; 2021 Apr; 10(4):. PubMed ID: 33924474
[TBL] [Abstract][Full Text] [Related]
9. CXCR2 antagonism promotes oligodendrocyte precursor cell differentiation and enhances remyelination in a mouse model of multiple sclerosis.
Wang L; Yang H; Zang C; Dong Y; Shang J; Chen J; Wang Y; Liu H; Zhang Z; Xu H; Bao X; Zhang D
Neurobiol Dis; 2020 Feb; 134():104630. PubMed ID: 31678404
[TBL] [Abstract][Full Text] [Related]
10. E6020, a synthetic TLR4 agonist, accelerates myelin debris clearance, Schwann cell infiltration, and remyelination in the rat spinal cord.
Church JS; Milich LM; Lerch JK; Popovich PG; McTigue DM
Glia; 2017 Jun; 65(6):883-899. PubMed ID: 28251686
[TBL] [Abstract][Full Text] [Related]
11. HMG-CoA reductase inhibitor augments survival and differentiation of oligodendrocyte progenitors in animal model of multiple sclerosis.
Paintlia AS; Paintlia MK; Khan M; Vollmer T; Singh AK; Singh I
FASEB J; 2005 Sep; 19(11):1407-21. PubMed ID: 16126908
[TBL] [Abstract][Full Text] [Related]
12. Treatment with metallothionein prevents demyelination and axonal damage and increases oligodendrocyte precursors and tissue repair during experimental autoimmune encephalomyelitis.
Penkowa M; Hidalgo J
J Neurosci Res; 2003 Jun; 72(5):574-86. PubMed ID: 12749022
[TBL] [Abstract][Full Text] [Related]
13. A dual effect of ursolic acid to the treatment of multiple sclerosis through both immunomodulation and direct remyelination.
Zhang Y; Li X; Ciric B; Curtis MT; Chen WJ; Rostami A; Zhang GX
Proc Natl Acad Sci U S A; 2020 Apr; 117(16):9082-9093. PubMed ID: 32253301
[TBL] [Abstract][Full Text] [Related]
14. Nudging oligodendrocyte intrinsic signaling to remyelinate and repair: Estrogen receptor ligand effects.
Khalaj AJ; Hasselmann J; Augello C; Moore S; Tiwari-Woodruff SK
J Steroid Biochem Mol Biol; 2016 Jun; 160():43-52. PubMed ID: 26776441
[TBL] [Abstract][Full Text] [Related]
15. CXCR2 signaling protects oligodendrocytes and restricts demyelination in a mouse model of viral-induced demyelination.
Hosking MP; Tirotta E; Ransohoff RM; Lane TE
PLoS One; 2010 Jun; 5(6):e11340. PubMed ID: 20596532
[TBL] [Abstract][Full Text] [Related]
16. Treatment with a recombinant human IgM that recognizes PSA-NCAM preserves brain pathology in MOG-induced experimental autoimmune encephalomyelitis.
Lemus HN; Warrington AE; Denic A; Wootla B; Rodriguez M
Hum Antibodies; 2017; 25(3-4):121-129. PubMed ID: 28269761
[TBL] [Abstract][Full Text] [Related]
17. Bu Shen Yi Sui capsule promotes remyelination correlating with Sema3A/NRP-1, LIF/LIFR and Nkx6.2 in mice with experimental autoimmune encephalomyelitis.
Zhao PY; Wang YQ; Liu XH; Zhu YJ; Zhao H; Zhang QX; Qi F; Li JL; Zhang N; Fan YP; Li KN; Zhao YY; Lei JF; Wang L
J Ethnopharmacol; 2018 May; 217():36-48. PubMed ID: 29428242
[TBL] [Abstract][Full Text] [Related]
18. ACT-1004-1239, a first-in-class CXCR7 antagonist with both immunomodulatory and promyelinating effects for the treatment of inflammatory demyelinating diseases.
Pouzol L; Baumlin N; Sassi A; Tunis M; Marrie J; Vezzali E; Farine H; Mentzel U; Martinic MM
FASEB J; 2021 Mar; 35(3):e21431. PubMed ID: 33595155
[TBL] [Abstract][Full Text] [Related]
19. Drug-based modulation of endogenous stem cells promotes functional remyelination in vivo.
Najm FJ; Madhavan M; Zaremba A; Shick E; Karl RT; Factor DC; Miller TE; Nevin ZS; Kantor C; Sargent A; Quick KL; Schlatzer DM; Tang H; Papoian R; Brimacombe KR; Shen M; Boxer MB; Jadhav A; Robinson AP; Podojil JR; Miller SD; Miller RH; Tesar PJ
Nature; 2015 Jun; 522(7555):216-20. PubMed ID: 25896324
[TBL] [Abstract][Full Text] [Related]
20. Remyelination induced by a DNA aptamer in a mouse model of multiple sclerosis.
Nastasijevic B; Wright BR; Smestad J; Warrington AE; Rodriguez M; Maher LJ
PLoS One; 2012; 7(6):e39595. PubMed ID: 22761835
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
